JP2019026646A - 含窒素複素環および炭素環誘導体を含有する、疼痛の治療および／または予防用医薬組成物 - Google Patents
含窒素複素環および炭素環誘導体を含有する、疼痛の治療および／または予防用医薬組成物 Download PDFInfo
- Publication number
- JP2019026646A JP2019026646A JP2018145568A JP2018145568A JP2019026646A JP 2019026646 A JP2019026646 A JP 2019026646A JP 2018145568 A JP2018145568 A JP 2018145568A JP 2018145568 A JP2018145568 A JP 2018145568A JP 2019026646 A JP2019026646 A JP 2019026646A
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- group
- aromatic heterocyclic
- aromatic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C*(C)(C)C*c(cc1)cnc1C(N(*)*)=O Chemical compound C*(C)(C)C*c(cc1)cnc1C(N(*)*)=O 0.000 description 46
- YOJDHQLEQUUNOS-UHFFFAOYSA-N CC([I]=N1)=CN=C1OCCO Chemical compound CC([I]=N1)=CN=C1OCCO YOJDHQLEQUUNOS-UHFFFAOYSA-N 0.000 description 2
- JDHARDHUMOHKMW-UHFFFAOYSA-N CC1=CN=C(CO)N=[I]1 Chemical compound CC1=CN=C(CO)N=[I]1 JDHARDHUMOHKMW-UHFFFAOYSA-N 0.000 description 2
- FWUZFIHIWKVHPD-MRXNPFEDSA-N C(c1ccccc1)N(CC1)[C@H]1c1ccccc1 Chemical compound C(c1ccccc1)N(CC1)[C@H]1c1ccccc1 FWUZFIHIWKVHPD-MRXNPFEDSA-N 0.000 description 1
- CTEZDKJVYPBFAO-UHFFFAOYSA-N CC(C)(C)OC(N(CCC1c(cc2)cc(F)c2F)CC1NC(Nc1c(C)c(-c2c[n](C)nc2)n[n]1-c1ccccc1)=O)=O Chemical compound CC(C)(C)OC(N(CCC1c(cc2)cc(F)c2F)CC1NC(Nc1c(C)c(-c2c[n](C)nc2)n[n]1-c1ccccc1)=O)=O CTEZDKJVYPBFAO-UHFFFAOYSA-N 0.000 description 1
- UDSPQHXXWGSCPO-UHFFFAOYSA-N CC(C)Cc(cn1)ccc1[Re] Chemical compound CC(C)Cc(cn1)ccc1[Re] UDSPQHXXWGSCPO-UHFFFAOYSA-N 0.000 description 1
- NKHUXEJVOGRXRN-UHFFFAOYSA-N CC([I]=N1)=CN=C1[Re] Chemical compound CC([I]=N1)=CN=C1[Re] NKHUXEJVOGRXRN-UHFFFAOYSA-N 0.000 description 1
- XCJDVHSFMRNAQR-QTZNENSDSA-N C[C@@H](/C=C\C([Re])=N)C(C)=C Chemical compound C[C@@H](/C=C\C([Re])=N)C(C)=C XCJDVHSFMRNAQR-QTZNENSDSA-N 0.000 description 1
- XVDSQMQDJPKOQP-UHFFFAOYSA-N C[n]1nc(C2OCCC2)cc1NC(NC(CCCC1)C1[n]1nccc1)=O Chemical compound C[n]1nc(C2OCCC2)cc1NC(NC(CCCC1)C1[n]1nccc1)=O XVDSQMQDJPKOQP-UHFFFAOYSA-N 0.000 description 1
- KMBVMOJQYKZBAG-GHTZIAJQSA-N Cc(c(Br)c1NC(N[C@H](CN(CCOC)C2)[C@@H]2c(cc2)cc(F)c2F)=N)n[n]1-c1ccccc1 Chemical compound Cc(c(Br)c1NC(N[C@H](CN(CCOC)C2)[C@@H]2c(cc2)cc(F)c2F)=N)n[n]1-c1ccccc1 KMBVMOJQYKZBAG-GHTZIAJQSA-N 0.000 description 1
- AISAUUOLNNOPNX-AVCGJXAMSA-N Cc(nc1)ccc1-c1n[n](C)c(NC(N[C@H](C[C@@H](CCOC)C2)[C@@H]2c2ccccc2)=O)c1 Chemical compound Cc(nc1)ccc1-c1n[n](C)c(NC(N[C@H](C[C@@H](CCOC)C2)[C@@H]2c2ccccc2)=O)c1 AISAUUOLNNOPNX-AVCGJXAMSA-N 0.000 description 1
- LLQCTIGFAWFVBR-RBDMOPTHSA-N Cc(nc1)ncc1-c1n[n](C)c(NC(N[C@H](C[C@@H](CCOC)C2)[C@@H]2c2ccccc2)=O)c1 Chemical compound Cc(nc1)ncc1-c1n[n](C)c(NC(N[C@H](C[C@@H](CCOC)C2)[C@@H]2c2ccccc2)=O)c1 LLQCTIGFAWFVBR-RBDMOPTHSA-N 0.000 description 1
- NDGXQZCDGFUJLU-UHFFFAOYSA-N Cc1c(NC(N)=O)[n](-c2ccccc2)nc1-c1c[n](C)nc1 Chemical compound Cc1c(NC(N)=O)[n](-c2ccccc2)nc1-c1c[n](C)nc1 NDGXQZCDGFUJLU-UHFFFAOYSA-N 0.000 description 1
- LVVXEBOLSSLZHW-UHFFFAOYSA-N Cc1c(NC(NC(CN(CCOC)CC2)C2c(cc2)cc(F)c2F)=O)[n](-c2ccccc2)nc1-c1c[n](C)nc1 Chemical compound Cc1c(NC(NC(CN(CCOC)CC2)C2c(cc2)cc(F)c2F)=O)[n](-c2ccccc2)nc1-c1c[n](C)nc1 LVVXEBOLSSLZHW-UHFFFAOYSA-N 0.000 description 1
- QQHHSKPCWJPVNE-UHFFFAOYSA-N Cc1c(NC(NC(CNCC2)C2c(cc2)cc(F)c2F)=O)[n](-c2ccccc2)nc1-c1c[n](C)nc1 Chemical compound Cc1c(NC(NC(CNCC2)C2c(cc2)cc(F)c2F)=O)[n](-c2ccccc2)nc1-c1c[n](C)nc1 QQHHSKPCWJPVNE-UHFFFAOYSA-N 0.000 description 1
- CTSPAJXVOWKTJZ-UHFFFAOYSA-N Cc1c(NC(NC2C(Cc(cc3)ccc3Cl)CCCC2)=O)[n](-c2ccccc2)nc1-c1c[n](C)nc1 Chemical compound Cc1c(NC(NC2C(Cc(cc3)ccc3Cl)CCCC2)=O)[n](-c2ccccc2)nc1-c1c[n](C)nc1 CTSPAJXVOWKTJZ-UHFFFAOYSA-N 0.000 description 1
- CAIKHRVXKJZPAS-IUGBQFMMSA-N Cc1c(NC(N[C@H](C[C@@H](CCOC)C2)[C@@H]2c(cc2F)ccc2F)=O)[n](-c2ccccc2)nc1-c1cnc(C)nc1 Chemical compound Cc1c(NC(N[C@H](C[C@@H](CCOC)C2)[C@@H]2c(cc2F)ccc2F)=O)[n](-c2ccccc2)nc1-c1cnc(C)nc1 CAIKHRVXKJZPAS-IUGBQFMMSA-N 0.000 description 1
- PXHLELBVKARRDH-WDDWZANVSA-N Cc1c(NC(N[C@H](C[C@@H](CCOC)C2)[C@@H]2c2ccccc2)=O)[n](-c2ccccc2)nc1-c1cnc(C)nc1 Chemical compound Cc1c(NC(N[C@H](C[C@@H](CCOC)C2)[C@@H]2c2ccccc2)=O)[n](-c2ccccc2)nc1-c1cnc(C)nc1 PXHLELBVKARRDH-WDDWZANVSA-N 0.000 description 1
- HHMUXUOAVKYSCV-OUIFVKKZSA-N Cc1c(NC(N[C@H](C[C@@H](CCOC)C2)[C@@H]2c2ccccc2)=O)[n](-c2ccccc2)nc1-c1cnc(CO)nc1 Chemical compound Cc1c(NC(N[C@H](C[C@@H](CCOC)C2)[C@@H]2c2ccccc2)=O)[n](-c2ccccc2)nc1-c1cnc(CO)nc1 HHMUXUOAVKYSCV-OUIFVKKZSA-N 0.000 description 1
- WFZWDGOKFGKDMK-WDJPJFJCSA-N Cc1c(NC(N[C@H](C[C@@H](CCOC)C2)[C@@H]2c2ccnc(Cl)c2)=O)[n](-c2ccccc2)nc1-c1c[n](C)nc1 Chemical compound Cc1c(NC(N[C@H](C[C@@H](CCOC)C2)[C@@H]2c2ccnc(Cl)c2)=O)[n](-c2ccccc2)nc1-c1c[n](C)nc1 WFZWDGOKFGKDMK-WDJPJFJCSA-N 0.000 description 1
- RUDSOGRXFMUEAZ-RJRADHEHSA-N Cc1c(NC(N[C@H]2[C@H](c(cc3)cc(F)c3F)N(C)[C@H](CCOC)C2)=O)[n](-c2ccccc2)nc1-c1cnc(C)nc1 Chemical compound Cc1c(NC(N[C@H]2[C@H](c(cc3)cc(F)c3F)N(C)[C@H](CCOC)C2)=O)[n](-c2ccccc2)nc1-c1cnc(C)nc1 RUDSOGRXFMUEAZ-RJRADHEHSA-N 0.000 description 1
- KMVSQVRYIZVSJB-LQCMOVKCSA-N Cc1c(NC(N[C@H]2[C@H](c(cc3F)ccc3F)N[C@H](CCOC)C2)=O)[n](-c2ccccc2)nc1-c(cc1)cnc1OC Chemical compound Cc1c(NC(N[C@H]2[C@H](c(cc3F)ccc3F)N[C@H](CCOC)C2)=O)[n](-c2ccccc2)nc1-c(cc1)cnc1OC KMVSQVRYIZVSJB-LQCMOVKCSA-N 0.000 description 1
- HQPGLMJFRAXHNN-RMXYQJDTSA-N Cc1c(NC(N[C@H]2[C@H](c(cc3F)ccc3F)N[C@H](CCOC)C2)=O)[n](-c2ccccc2)nc1-c1cnc(C)nc1 Chemical compound Cc1c(NC(N[C@H]2[C@H](c(cc3F)ccc3F)N[C@H](CCOC)C2)=O)[n](-c2ccccc2)nc1-c1cnc(C)nc1 HQPGLMJFRAXHNN-RMXYQJDTSA-N 0.000 description 1
- SZQCPPRPWDXLMM-UHFFFAOYSA-N Cc1c[n](C)nc1 Chemical compound Cc1c[n](C)nc1 SZQCPPRPWDXLMM-UHFFFAOYSA-N 0.000 description 1
- XTHGETUOTFHFDY-UHFFFAOYSA-N O=C(NC(CCCC1)C1[n]1nccc1)Nc1ccn[n]1CC1COCC1 Chemical compound O=C(NC(CCCC1)C1[n]1nccc1)Nc1ccn[n]1CC1COCC1 XTHGETUOTFHFDY-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017150341 | 2017-08-03 | ||
| JP2017150341 | 2017-08-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019026646A true JP2019026646A (ja) | 2019-02-21 |
| JP2019026646A5 JP2019026646A5 (enExample) | 2021-08-19 |
Family
ID=65477645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018145568A Pending JP2019026646A (ja) | 2017-08-03 | 2018-08-02 | 含窒素複素環および炭素環誘導体を含有する、疼痛の治療および／または予防用医薬組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2019026646A (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022218289A1 (en) * | 2021-04-12 | 2022-10-20 | Cullgen (Shanghai), Inc. | Tropomyosin receptor kinase (trk) degradation compounds and methods of use |
| JP2023085798A (ja) * | 2021-12-09 | 2023-06-21 | ヘンケルジャパン株式会社 | ホットメルト接着剤 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014514360A (ja) * | 2011-05-13 | 2014-06-19 | アレイ バイオファーマ、インコーポレイテッド | Ｔｒｋａキナーゼ阻害剤としてのピロリジニル尿素およびピロリジニルチオ尿素化合物 |
| WO2015175788A1 (en) * | 2014-05-15 | 2015-11-19 | Array Biopharma Inc. | 1-((3s,4r)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1h-pyrazol-5-yl)urea as a trka kinase inhibitor |
| JP2016501191A (ja) * | 2012-11-13 | 2016-01-18 | アレイ バイオファーマ、インコーポレイテッド | Ｔｒｋａキナーゼ阻害剤としてのｎ−ピロリジニル、ｎ’−ピラゾリル尿素、チオ尿素、グアニジン、およびシアノグアニジン化合物 |
| WO2016021629A1 (ja) * | 2014-08-06 | 2016-02-11 | 塩野義製薬株式会社 | ＴｒｋＡ阻害活性を有する複素環および炭素環誘導体 |
-
2018
- 2018-08-02 JP JP2018145568A patent/JP2019026646A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014514360A (ja) * | 2011-05-13 | 2014-06-19 | アレイ バイオファーマ、インコーポレイテッド | Ｔｒｋａキナーゼ阻害剤としてのピロリジニル尿素およびピロリジニルチオ尿素化合物 |
| JP2016501191A (ja) * | 2012-11-13 | 2016-01-18 | アレイ バイオファーマ、インコーポレイテッド | Ｔｒｋａキナーゼ阻害剤としてのｎ−ピロリジニル、ｎ’−ピラゾリル尿素、チオ尿素、グアニジン、およびシアノグアニジン化合物 |
| WO2015175788A1 (en) * | 2014-05-15 | 2015-11-19 | Array Biopharma Inc. | 1-((3s,4r)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1h-pyrazol-5-yl)urea as a trka kinase inhibitor |
| WO2016021629A1 (ja) * | 2014-08-06 | 2016-02-11 | 塩野義製薬株式会社 | ＴｒｋＡ阻害活性を有する複素環および炭素環誘導体 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022218289A1 (en) * | 2021-04-12 | 2022-10-20 | Cullgen (Shanghai), Inc. | Tropomyosin receptor kinase (trk) degradation compounds and methods of use |
| AU2022256612B2 (en) * | 2021-04-12 | 2025-09-11 | Cullgen (Shanghai), Inc. | Tropomyosin receptor kinase (trk) degradation compounds and methods of use |
| JP2023085798A (ja) * | 2021-12-09 | 2023-06-21 | ヘンケルジャパン株式会社 | ホットメルト接着剤 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6898043B2 (ja) | ＴｒｋＡ阻害活性を有する含窒素複素環および炭素環誘導体 | |
| JP6618120B2 (ja) | ＴｒｋＡ阻害活性を有する複素環および炭素環誘導体 | |
| JP6812059B2 (ja) | ＴｒｋＡ阻害活性を有する複素環誘導体 | |
| JP2019001806A (ja) | 新規アルキレン誘導体 | |
| US20180362543A1 (en) | Hiv replication inhibitor | |
| WO2018079759A1 (ja) | ＴｒｋＡ阻害活性を有する縮合複素環および縮合炭素環誘導体 | |
| JPWO2013146754A1 (ja) | Ｔｒｐｖ４阻害活性を有する芳香族複素５員環誘導体 | |
| JP2016079168A (ja) | ９員縮合環誘導体 | |
| TW201908313A (zh) | 具有ｍｇａｔ２抑制活性的縮合環衍生物 | |
| JP6579549B2 (ja) | Ｈｉｖ複製阻害作用を有する３環性複素環誘導体 | |
| JPWO2018021447A1 (ja) | ドーパミンｄ３受容体拮抗作用を有する含窒素縮環化合物 | |
| WO2017069224A1 (ja) | Ｍｇａｔ２阻害活性を有するスピロ環誘導体 | |
| WO2015199206A1 (ja) | Ｔｒｐｖ４阻害活性を有する６員環誘導体 | |
| WO2017204316A1 (ja) | ５－オキソ－１，２，４－トリアジン誘導体およびその医薬組成物 | |
| WO2018074390A1 (ja) | 二環性含窒素複素環誘導体およびそれらを含有する医薬組成物 | |
| JP2019182806A (ja) | 二環性複素環誘導体およびそれらを含有する医薬組成物 | |
| JPWO2016098793A1 (ja) | 環状グアニジル基を有するチアゾール誘導体 | |
| WO2017110841A1 (ja) | Ｍｇａｔ２阻害活性を有する非芳香族複素環誘導体 | |
| CN115093408B (zh) | 可用于抗分枝杆菌感染的含有苄胺的5,6-杂芳族化合物 | |
| JP2014080395A (ja) | アミノラクタム誘導体およびそれらを含有する医薬組成物 | |
| WO2017209267A1 (ja) | プリン誘導体 | |
| JP7250405B2 (ja) | ドーパミンｄ３受容体拮抗作用を有する環式化合物 | |
| JP2019189573A (ja) | 縮合複素環および縮合炭素環誘導体を含有する、疼痛の治療および／または予防用医薬組成物 | |
| JP2019127467A (ja) | ドーパミンｄ３受容体拮抗作用を有する含窒素縮環化合物を含有する医薬組成物 | |
| JP6692113B2 (ja) | ６員複素環誘導体を含有する医薬組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210709 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210709 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20220427 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220510 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20221102 |